Загрузка...
Trial watch: Peptide-based vaccines in anticancer therapy
Peptide-based anticancer vaccination aims at stimulating an immune response against one or multiple tumor-associated antigens (TAAs) following immunization with purified, recombinant or synthetically engineered epitopes. Despite high expectations, the peptide-based vaccines that have been explored i...
Сохранить в:
| Опубликовано в: : | Oncoimmunology |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Taylor & Francis
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6279318/ https://ncbi.nlm.nih.gov/pubmed/30524907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1511506 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|